Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.77 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 4/20 | 0.58 |
| ▸ | CNR1 | P21554 | 2/20 | 0.58 |
| ▸ | CNR2 | P34972 | 2/20 | 0.58 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.49 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.49 |
| ▸ | ITGAL | P20701 | 2/20 | 0.49 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.48 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29713992 | 1.00 | SLC6A5 (0.77) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL26624581 | 0.94 | SLC6A5 (0.89) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL17817155 | 0.93 | SLC6A5 (0.87) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL22034112 | 0.93 | SLC6A5 (0.87) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL15649758 | 0.93 | SLC6A5 (0.87) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL15650015 | 0.93 | SLC6A5 (0.87) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL17204083 | 0.93 | SLC6A5 (0.87) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL4348859 | 0.93 | SLC6A5 (0.87) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL13279669 | 0.93 | SLC6A5 (0.87) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL9664374 | 0.93 | SLC6A5 (0.87) | SLC6A5EPHX2FAAHCNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | ANTEIS SA (CH) | 2022-05-17 | — | — | US | disclosed |
| US-10543195-B2 | Peptides for skin rejuvenation and methods of using the same | ANTEIS SA (CH) | 2020-01-28 | — | — | US | disclosed |
| EP-2970382-B1 | PEPTIDES FOR SKIN REJUVENATION AND METHODS OF USING THE SAME | ANTEIS SA (CH) | 2019-09-25 | — | — | EP | disclosed |
| US-20160271109-A1 | Peptides For Skin Rejuvenation And Methods Of Using The Same | ANTEIS SA (CH) | 2016-09-22 | — | — | US | disclosed |
| US-9375398-B2 | Peptides for skin rejuvenation and methods of using the same | NEOCUTIS S.A. (CH) | 2016-06-28 | — | — | US | disclosed |
| US-20140309173-A1 | Peptides For Skin Rejuvenation And Methods Of Using The Same | ANTEIS SA (CH) | 2014-10-16 | — | — | US | disclosed |
| WO-2014140890-A2 | PEPTIDES FOR SKIN REJUVENATION AND METHODS OF USING THE SAME | NEOCUTIS SA (CH) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | CUTA, PLOD3, MMP13 | SLC6A5 2755/4885EPHX2 2518/4885FAAH 1985/4885 |
| US-10543195-B2 | Peptides for skin rejuvenation and methods of using the same | CUTA, PLOD3, MMP13 | SLC6A5 2755/4885EPHX2 2518/4885FAAH 1985/4885 |
| US-20160271109-A1 | Peptides For Skin Rejuvenation And Methods Of Using The Same | CUTA, PLOD3, MMP13 | SLC6A5 2755/4885EPHX2 2518/4885FAAH 1985/4885 |
| US-20140309173-A1 | Peptides For Skin Rejuvenation And Methods Of Using The Same | CUTA, PLOD3, MMP13 | SLC6A5 2755/4885EPHX2 2518/4885FAAH 1985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.